RxDoctor Payments Data

Rachel Balkema, PA

Physician Assistant · Muskegon, MINPI 1356776207

Payments from drug & device makers

$7,358in general payments, 2019–2025

Across 376 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • EMD Serono, Inc.$1K
  • Lundbeck LLC$729
  • Amgen$386
  • Teva Pharmaceuticals USA, Inc.$351
  • Novartis$266
  • plus $3K from 37 others

What the payments were for

  • Food & beverage$7,358100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$7,358 in reported general payments places this provider in the 95th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$14,073
Medicare patients
89
Services billed
163

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov5017$226,892
Aimovig AutoinjectorErenumab-Aooe225$170,482
NuplazidPimavanserin Tartrate31$144,262
UbrelvyUbrogepant106$129,129
Nurtec OdtRimegepant Sulfate34$46,761
Emgality PenGalcanezumab-Gnlm57$45,571
QuliptaAtogepant37$36,883
Ajovy AutoinjectorFremanezumab-Vfrm22$30,117
RexultiBrexpiprazole17$24,944
NuedextaDextromethorphan Hbr/Quinidine11$16,544
Carbidopa-LevodopaCarbidopa/Levodopa185$9,219
Emgality SyringeGalcanezumab-Gnlm14$8,782
Propranolol Hcl ErPropranolol Hcl108$5,140
Entacapone27$4,994
Primidone60$4,434

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid$28$226,89217 claims
AbbVieUbrelvy, Qulipta$1,745$166,012143 claims
Acadia Pharmaceuticals IncNuplazid$128$144,26231 claims
PfizerNurtec Odt$224$46,76134 claims
Otsuka America Pharmaceutical, Inc.Rexulti$165$24,94417 claims
Avanir Pharmaceuticals, Inc.Nuedexta$17$16,54411 claims
Amneal Pharmaceuticals LLCPyridostigmine Bromide$28$1,91518 claims
Upsher-smith Laboratories LLCTopiramate$189$1,700117 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Muskegon

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →